TickerFacts.

NeoGenomics Inc (NEO): Gross Profit

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$314.29M
Year ended 2025-12-31
$336.53M
Trailing 12 months to 2026-06-30
+18.7%
3-year compound annual growth
+11.1%
5-year compound annual growth
2010-12-31: $15.78M2011-12-31: $19.43M2012-12-31: $26.84M2013-12-31: $31.74M2014-12-31: $40.71M2015-12-31: $43.76M2016-12-31: $98.10M2017-12-31: $101.96M2018-12-31: $127.27M2019-12-31: $196.84M2020-12-31: $185.89M2021-12-31: $187.06M2022-12-31: $187.90M2023-12-31: $244.60M2024-12-31: $290.10M2025-12-31: $314.29M$314.29M
2010-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$314.29M+8.3%2026-02-17, From 2025-01-01
2024-12-31$290.10M+18.6%2026-02-17, From 2024-01-01
2023-12-31$244.60M+30.2%2026-02-17, From 2023-01-01
2022-12-31$187.90M+0.4%2025-02-18, From 2022-01-01
2021-12-31$187.06M+0.6%2024-02-20, From 2021-01-01
2020-12-31$185.89M-5.6%2023-02-24, From 2020-01-01
2019-12-31$196.84M+54.7%2022-02-25, From 2019-01-01
2018-12-31$127.27M+24.8%2021-02-25, From 2018-01-01
2017-12-31$101.96M+3.9%2020-02-28, From 2017-01-01
2016-12-31$98.10Mn/c2019-02-26, From 2016-01-01
2015-12-31$43.76M+7.5%2018-03-13, From 2015-01-01
2014-12-31$40.71M+28.3%2017-03-14, From 2014-01-01
2013-12-31$31.74M+18.3%2016-04-18, From 2013-01-01
2012-12-31$26.84M+38.1%2015-03-03, From 2012-01-01
2011-12-31$19.43M+23.1%2014-02-24, From 2011-01-01
2010-12-31$15.78Mn/a2012-03-12, From 2010-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
NeoGenomics Inc (NEO)2025-12-31$314.29M+8.3%
UL Solutions Inc. (ULS)2025-12-31$1.51B+8.5%
Incyte Corp (INCY)2025-12-31$4.77B+21.4%
Icon PLC (ICLR)2024-12-31$2.34B+0.4%
MaxCyte, Inc. (MXCT)2025-12-31$26.80M-15.0%
20/20 Biolabs, Inc. (AIDX)2025-12-31$604.5K+67.8%
iSpecimen Inc. (ISPC)2025-12-31$24.1K-99.4%
OneMedNet Corp (ONMD)2025-12-31-$503.0Kn/m
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31$262.9K+29.4%

Compare NEO, ULS, INCY, ICLR side by side · Screen every company in Services-Testing Laboratories ↗